PRIMA Migraine Clinical Trial | AGA Medical Corporation

THE HEART AND MIGRAINE CONNECTION
The PRIMA Trial is a clinical study designed to evaluate the effectiveness of PFO closure as a treatment for migraine with aura. PFO closure is performed by placing an occlusion device into the PFO through a catheter in a catheterization laboratory. The trial will measure and compare headache frequency and severity from those who receive PFO closure to those who do not.

The AMPLATZER PFO Occluder
closes the PFO to prevent blood
from shunting to left side of
the heart.

REFERRAL INQUIRY
For more information on the PRIMA Trial, please complete the referral inquiry form.

* = Required Field